2018 Diagnostic Pathology Update


July 8, 2018 to July 13, 2018
Santa Apollonia, Via San Gallo, 25, Florence, Italy

2018 Diagnostic Pathology Update
Adam Bagg

Adam Bagg, MD
University of Pennsylvania

Co-Course Director

Dr. Adam Bagg is Director of Hematology at the University of Pennsylvania where he is a Professor of Pathology and Laboratory Medicine, in the Division of Hematopathology. For the past seven years he was voted by his peers as one of Philadelphia’s Top Doctors. Per US News & World Report he is in the top 1% of doctors in the United States. He has served on the USCAP Board of Directors and Education Committee. He lectures extensively nationally (at USCAP, ASCP, AMP, CAP, ACLPS, AACC, ISLH and ASH) and internationally (Germany, Northern Ireland, India, China, South Korea, Singapore, South Africa, Brazil, Lebanon, Canada, Scotland, Mexico, Sudan, Turkey, Romania, Iran and Australia). Most of his more than 160 publications are on the molecular pathology of hematologic malignancies. A publication that he co-authored (CART19 T-cells to treat CLL) was the most downloaded article in Science Translational Medicine for 2011. He is an Associate Editor of the Journal of Molecular Diagnostics and on the Editorial Board of Advances in Anatomic Pathology.

Rhonda K. Yantiss

Rhonda K. Yantiss, MD
Weill Cornell Medicine

Co-Course Director

Dr. Yantiss received her undergraduate degree from the University of Kansas and graduated from Harvard Medical School. She completed her residency in anatomic pathology at the Massachusetts General Hospital, followed by fellowship training in gastrointestinal and liver pathology at the Beth Israel Deaconess Medical Center.  She is currently a Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College where she is the director of the gastrointestinal and liver pathology service.  Dr. Yantiss has chaired the Nominations and Education Committees of the Rodger C. Haggitt Gastrointestinal Pathology Society and served as President of that society.  She is Chair of the Abstract Review Board and Assignment Committee, a former member of the Education Committee and prior member of the Ramzi Cotran Young Investigator Award Committee of the United States and Canadian Academy of Pathology.  Dr. Yantiss lectures widely in the United States and abroad and is the Course Director of the Tutorial on Pathology of the GI Tract, Pancreas, and Liver. She has received several teaching and professional awards, including the Arthur Purdy Stout Society of Pathology Annual Prize. Dr. Yantiss has published more than 150 articles, books, and book chapters related to gastrointestinal pathology.  She serves as an ad hoc reviewer for fifteen journals and member of the editorial boards of the Archives of Pathology and Laboratory Medicine, Modern Pathology, American Journal of Clinical Pathology, Seminars in Diagnostic Pathology, and The American Journal of Surgical Pathology; she is also an Associate Editor of Archives of Pathology and Laboratory​.

Jonathan Epstein

Jonathan Epstein, MD
The Johns Hopkins Medical Institutions

Dr. Epstein obtained a combined B.A.-M.D. degree from Boston University’s 6-Year Medical Program (1975–1981). Following his residency in anatomic pathology at The Johns Hopkins Hospital in Baltimore, Maryland and a fellowship in oncologic pathology at Memorial Sloan Kettering Cancer Center in New York, he joined the staff at The Johns Hopkins Hospital and has been there his entire career. At The Johns Hopkins Medical Institutions, he is Professor of Pathology, Urology, and Oncology; the recipient of the Reinhard Chair of Urological Pathology; and Director of Surgical Pathology. He is the past President of the International Society of Urological Pathology. Dr Epstein has 844 publications in the peer-reviewed literature and has authored 69 book chapters with a H-factor of 131. His most-frequently cited first or last authored publications is ‘‘Pathological and Clinical Findings to Predict Tumor Extent of Nonpalpable (stage T1c) Prostate Cancer,’’ published in JAMA, which establishes the criteria for active surveillance. He was also the leading author to develop the WHO Consensus Conference on Classification of Urothelial Neoplasia (1998) and the consensus on updating the Gleason grading system (2005, 2015). He is the author or coauthor of 7 books including “Interpretation of Prostate Biopsies” which is in its 5th edition, and “Bladder Biopsy Interpretation” which is in its 3rd edition. He is a co-editor of the “WHO Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs”, and a co-author of the 2011 AFIP Fascicle, 4th Series on “Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis”. More recently, he authored or co-authored “The Gleason Grading System: A complete Guide for Pathologists and Clinicians” and “Differential Diagnoses in Surgical Pathology: Genitourinary System”. Dr. Epstein has proposed a new Grade Group system for prostate cancer that has been accepted by the WHO, 8th Edition of the TNM Staging Manual, and the CAP. Dr. Epstein has one of the largest surgical pathology consulting services in the world with approximately 12,000 cases per year, covering the full range of urologic pathology. Dr. Epstein uses these consultations to train 4 genitourinary pathology fellows each year, with 61 fellows trained to date. He has lectured 363 times outside of his institution including 41 different countries.

William C. Faquin

William C. Faquin, MD, PhD
Massachusetts General Hospital / Harvard Medical School

Dr. Faquin is the Director of Head and Neck Pathology at the Massachusetts General Hospital and the Massachusetts Eye and Ear Infirmary in Boston, MA. He is a Professor of Pathology at Harvard Medical School, and is recognized for his dedication to teaching and contributions to the field of head and neck pathology and cytology. He has authored over 250 peer-reviewed publications, and has co-authored books on head and neck cytohistology, salivary gland cytopathology, and thyroid cytopathology. Dr. Faquin is currently the co-chair of the College of American Pathologists Evidence-Based Guidelines Committee developing national guidelines for the testing of head and neck squamous cell carcinomas for high-risk HPV. He is also co-chair of the Milan System for Reporting Salivary Gland Cytopathology sponsored by the ASC and IAC. Dr. Faquin has been selected as successor to Dr. Celeste N. Powers as Editor-in-Chief of Cancer Cytopathology.

Jason L. Hornick

Jason L. Hornick, MD, PhD
Harvard Medical School

Dr. Jason Hornick received a B.A. from Amherst College (Amherst, MA) and an M.D./Ph.D. from the University of Southern California (Los Angeles, CA). He trained as a resident in Anatomic Pathology and pursued subspecialty fellowships in soft tissue pathology and gastrointestinal pathology at Brigham and Women’s Hospital (Boston, MA), where he is now the Director of Surgical Pathology and Immunohistochemistry. He is a Professor of Pathology at Harvard Medical School and a consultant at the Dana Farber Cancer Institute.

Dr. Hornick is Chair of the USCAP (United States and Canadian Academy of Pathology) Education Committee, past Chair of the USCAP Abstract Review Board and Assignment Committee, and past Chair of the Immunohistochemistry Committee for the CAP (College of American Pathologists). He was a member of the consensus and editorial working group for the 4th edition of the WHO (World Health Organization) Classification of Tumors of Soft Tissue and Bone and currently serves as an expert member of the editorial board for the 5th edition. Dr. Hornick has also contributed to the WHO Classifications of Tumors of the Digestive System, Skin Tumors, Tumors of the Urinary System and Male Genital Organs, and Tumors of the Breast. He was a member of the Soft Tissue Sarcoma Expert Panel for the AJCC (American Joint Committee on Cancer) and a member of the Sarcoma Analysis Working Group for The Cancer Genome Atlas (TCGA). He also serves on the Test Development and Advisory Committee for Anatomic Pathology for the American Board of Pathology.

Dr. Hornick serves on 12 editorial boards, including Modern Pathology and the American Journal of Surgical Pathology. He is a Regional Editor for Histopathology, an Associate Editor for Advances in Anatomic Pathology, the Consulting Editor for Surgical Pathology Clinics, and on the Executive Advisory Board of Archives of Pathology and Laboratory Medicine. Dr. Hornick is the Associate Editor for the American Registry of Pathology (formerly AFIP) Atlases. Dr. Hornick has published around 400 original papers, review articles, and book chapters and edited the textbook Practical Soft Tissue Pathology: A Diagnostic Approach, the 2nd edition of which was recently published. He is an Associate Editor for Sternberg’s Diagnostic Surgical Pathology.

Dr. Hornick received the 2012 Arthur Purdy Stout Society of Surgical Pathologists Annual Prize and the 2014 Jack Yardley Investigator Award from the Gastrointestinal Pathology Society.  He teaches courses on the diagnosis of soft tissue tumors, gastrointestinal pathology, and diagnostic immunohistochemistry.

Kirk D. Jones

Kirk D. Jones, MD
University of California San Francisco

Dr. Jones is Professor of Pathology at the University of California San Francisco. He did his undergraduate work at Brown University in Providence, Rhode Island, and graduated from UCSF Medical School in 1994. During his medical school training, he was introduced to pathology and participated in the post-sophomore fellowship program under the directorship of Dr. Linda Ferrell. He did his pathology residency training at UCSF, and continued there with a surgical pathology fellowship. He completed a cytopathology fellowship under the direction of Drs. Ted Miller, Britt-Marie Ljung, Doug Hanks, and Tere Darragh. He obtained additional training in pulmonary pathology as a visiting scholar to Mayo Clinic Scottsdale Arizona, learning from Drs. Tom Colby and Kevin Leslie.

Although Dr. Jones was cajoled by a senior faculty member to pursue pulmonary pathology, it has become one of his passions. He has given lectures and courses throughout the world, lecturing at the World Conference on Lung Cancer, the Pulmonary Pathology Society Biennial meetings, USCAP annual meetings, the American Thoracic Society International Conference, and the American College of Chest Physicians annual meetings. He was the pathologist for the visiting team of interstitial lung disease experts to the Guangzhou Institute for Respiratory Disease in 2016. He has authored over 75 peer-reviewed publications and 5 book chapters. He is on the editorial boards of the American Journal of Surgical Pathology and Archives of Pathology and Laboratory Medicine.

David S. Klimstra

David S. Klimstra, MD
Memorial Sloan Kettering Cancer Center

Dr. Klimstra is an Attending Pathologist and Chairman of the Department of Pathology, Memorial Sloan Kettering Cancer Center, and also a Professor of Pathology and Laboratory Medicine at Weill Medical College of Cornell University. He received his M.D. degree and completed his Anatomic Pathology Residency at Yale University, and undertook fellowship training in oncologic surgical pathology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert on the pathology of tumors of the digestive system, pancreas, liver and neuroendocrine system. His research focuses on the correlation of morphological and immunohistochemical features of tumors of the gastrointestinal tract, liver, biliary tree, and (most notably) pancreas with their clinical and molecular characteristics. He has contributed to the recent WHO classifications of pancreatic, gastrointestinal and neuroendocrine tumors. Dr. Klimstra has published over 350 primary articles and has co-authored the Armed Forces Institute of Pathology tumor fascicles on Tumors of the Pancreas and Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater, and he participated in the most recent WHO classifications of tumors of the Digestive System and of the Endocrine Organs. He has lectured world-wide on topics related to tumor pathology, and he has received several teaching awards.

Glenn McCluggage

Glenn McCluggage, FRCPath
Royal Group of Hospitals Trust, Belfast

Dr. McCluggage is a consultant Histopathologist in Royal Group of Hospitals Trust, Belfast and an Honorary Professor in Gynecological Pathology of Queen’s University of Belfast. He has published well over 400 papers in peer reviewed journals, including original publications and many invited editorials and reviews. He is on the Editorial Board of several major pathology journals and serves as Associate Editor of Histopathology. Dr. McCluggage is currently President of International Society of Gynecological Pathologists and was previously secretary of this society. Previously he was President of the British Association of Gynecological Pathologists. He has an extremely busy referral practice and has been invited to lecture at numerous national and international meetings. He has authored or co-authored the various Royal College of Pathologists datasets in the United Kingdom on reporting of gynecological malignancies and has chaired the ICCR (International Collaboration on Cancer Reporting) panels developing international guidelines for reporting endometrial, ovarian and cervical carcinomas. He has been part of the last two WHO groups formulating the classification of Tumours of the Female Genital Tract.

Stuart J. Schnitt

Stuart J. Schnitt, MD
Dana-Farber/Brigham and Women’s Cancer Center;
Harvard Medical School

Dr. Schnitt is the Chief of Breast Oncologic Pathology for the Dana-Farber/Brigham and Women’s Cancer Center, Associate Director of the Dana-Farber Cancer Institute/Brigham and Women’s Hospital Breast Oncology Program, co-leader of the Dana Farber Harvard Cancer Center Breast Program, Senior Pathologist at Brigham and Women’s Hospital, a Professor of Pathology at Harvard Medical School and an internationally recognized expert in breast pathology. He did his internship and residency in Anatomic and Clinical Pathology at Beth Israel Hospital in Boston followed by a fellowship in surgical pathology, also at Beth Israel Hospital. He was a faculty member in the Beth Israel Hospital/Beth Israel Deaconess Medical Center Department of Pathology from 1984-2017, including 11 years as Director of Anatomic Pathology and subsequently Vice Chair for Anatomic Pathology. He has published over 350 original articles, review articles, editorials, commentaries, and book chapters, primarily in the area of breast diseases. He has co-authored a popular textbook entitled “Biopsy Interpretation of the Breast”, now its third edition. The first two editions of this book were also published in Chinese. In addition, he is one of the editors of the 4th Edition of the “World Health Organization Classification of Tumours of the Breast”, published in 2012 and is serving as an editor of the upcoming 5th Edition of the “World Health Organization Classification of Tumours of the Breast”. Dr. Schnitt is a Past-President of the United States and Canadian Academy of Pathology (2010-2011). Other notable honors include the Arthur Purdy Stout Society of Surgical Pathologists Annual Prize (1999), the Albany Medical College Distinguished Alumnus Award (2014), the Lynn Sage Distinguished Lecturer (2014), the Maude Abbot Lecture at the United States and Canadian Academy of Pathology Annual Meeting (2016), the United States and Canadian Academy of Pathology F.K. Mostofi Distinguished Service Award (2018) and United States and Canadian Academy of Pathology Harvey Goldman Master Teacher Award (2019) and the International Society of Breast Pathology’s (ISBP) Breast Cancer Research Foundation Award (2019). He is particularly proud to have been involved in the training of 37 breast pathology fellows since 1995. He has lectured extensively around the world. His research interests and contributions to our understanding of benign breast diseases and breast cancer have been broad, having largely focused on risk factors for local recurrence in patients with invasive breast cancer and ductal carcinoma in situ treated with breast conserving therapy, benign breast disease and breast cancer risk, and stromal-epithelial interactions in breast tumor progression.


view more